Hakutulokset - Jean‐Louis Montastruc

Tarkenna hakua
  1. 1
    Adverse drug reactions and off-label drug use in paediatric outpatients

    Adverse drug reactions and off-label drug use in paediatric outpatients Tekijä Benjamin Horen, Jean‐Louis Montastruc, Maryse Lapeyre‐Mestre

    Julkaistu 2002
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Pioglitazone and bladder cancer

    Pioglitazone and bladder cancer Tekijä Dominique Hillaire‐Buys, Jean‐Luc Faillie, Jean‐Louis Montastruc

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database

    Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide... Tekijä Guillaume Moulis, Agnès Sommet, Maryse Lapeyre‐Mestre, Jean‐Louis Montastruc

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database

    Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database Tekijä Jean‐Louis Montastruc, Agnès Sommet, Haleh Bagheri, Maryse Lapeyre‐Mestre

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Pharmacoepidemiology and its input to pharmacovigilance

    Pharmacoepidemiology and its input to pharmacovigilance Tekijä Jean‐Luc Faillie, François Montastruc, Jean‐Louis Montastruc, Alexandre Pariente

    Julkaistu 2016
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Lipolytic effects of conventional <i>β</i><sub>3</sub>‐adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative <i>β</i><sub>4</sub>‐adrenoceptor

    Lipolytic effects of conventional <i>β</i><sub>3</sub>‐adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative <i>β<... Tekijä Jean Galitzky, Dominique Langin, Patrick Verwaerde, Jean‐Louis Montastruc, Max Lafontan, M Berlan

    Julkaistu 1997
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    French health insurance databases: What interest for medical research?

    French health insurance databases: What interest for medical research? Tekijä Guillaume Moulis, Maryse Lapeyre‐Mestre, Aurore Palmaro, G. Pugnet, Jean‐Louis Montastruc, L. Sailler

    Julkaistu 2014
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France

    Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France Tekijä Guillaume Moulis, Aurore Palmaro, Jean‐Louis Montastruc, Bertrand Godeau, Maryse Lapeyre‐Mestre, L. Sailler

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Square wave jerks in parkinsonian syndromes.

    Square wave jerks in parkinsonian syndromes. Tekijä Olivier Rascol, Umberto Sabatini, M. Simonetta‐Moreau, Jean‐Louis Montastruc, A Rascol, M. Clanet

    Julkaistu 1991
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence

    Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence Tekijä Matthieu Roustit, Romain Guilhaumou, Mathiéu Molimard, Milou‐Daniel Drici, Silvy Laporte, Jean‐Louis Montastruc

    Julkaistu 2020
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Case ascertainment and estimated incidence of drug‐induced long‐QT syndrome: study in Southwest France

    Case ascertainment and estimated incidence of drug‐induced long‐QT syndrome: study in Southwest France Tekijä Mariam Molokhia, Atul Pathak, Maryse Lapeyre‐Mestre, Laetitia Caturla, Jean Louis Montastruc, Paul McKeigue

    Julkaistu 2008
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses

    Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses Tekijä Guillaume Moulis, Agnès Sommet, Johana Béné, François Montastruc, L. Sailler, Jean‐Louis Montastruc, Maryse Lapeyre‐Mestre

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    What is pharmacoepidemiology? Definition, methods, interest and clinical applications

    What is pharmacoepidemiology? Definition, methods, interest and clinical applications Tekijä Jean‐Louis Montastruc, Justine Bénévent, François Montastruc, Haleh Bagheri, Fabien Despas, Maryse Lapeyre‐Mestre, Agnès Sommet

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database

    Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database Tekijä Jean‐Louis Montastruc, Margaux Lafaurie, Claire de Canecaude, Geneviève Durrieu, Agnès Sommet, François Montastruc, Haleh Bagheri

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Prevalence of orthostatic hypotension in Parkinson's disease

    Prevalence of orthostatic hypotension in Parkinson's disease Tekijä Jean‐Michel Sénard, Sharada Rai, Maryse Lapeyre‐Mestre, Christine Brefel, O. Rascol, A Rascol, Jean‐Louis Montastruc

    Julkaistu 1997
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?

    Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients? Tekijä Didier Concordet, Peggy Gandia, Jean‐Louis Montastruc, Alain Bousquet‐mélou, P. Lees, Aude Ferran, Pierre‐Louis Toutain

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Prevalence and Pharmacological Factors Associated With Impulse-Control Disorder Symptoms in Patients With Parkinson Disease

    Prevalence and Pharmacological Factors Associated With Impulse-Control Disorder Symptoms in Patients With Parkinson Disease Tekijä Santiago Perez‐Lloret, María Verónica Rey, Nelly Fabre, Fabienne Ory, Umberto Spampinato, Christine Brefel‐Courbon, Jean‐Louis Montastruc, Olivier Rascol

    Julkaistu 2012
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients

    The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients Tekijä Olivier Rascol, Umberto Sabatini, N Fabre, Christine Brefel, Isabelle Loubinoux, Pierre Celsis, Jean‐Michel Sénard, Jean‐Louis Montastruc, François Chollet

    Julkaistu 1997
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus

    Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus Tekijä Alain Weill, Michel Païta, Philippe Tuppin, Jean‐Paul Fagot, Anke Neumann, Dominique Simon, P. Ricordeau, Jean‐Louis Montastruc, H. Allemand

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa.

    Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. Tekijä Olivier Rascol, Umberto Sabatini, François Chollet, Nelly Fabre, Jean‐Michel Sénard, Jean‐Louis Montastruc, Pierre Celsis, J.P. Marc-Vergnes, A Rascol

    Julkaistu 1994
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: